Combined antegrade and retrograde esophageal dilation for head and neck cancer‐related complete esophageal stenosis
Authors:
- Laura A. GoguenLGLaura A. Goguen
- Donald J. AnninoDADonald J. Annino
- 8 December 2009
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 120 (2) , 261-266
Abstract
Objectives/Hypothesis: Assess the safety and efficacy of combined antegrade and retrograde esophageal dilation (CARD) for complete esophageal stenosis following head and neck cancer (HNC) treatment. Review HNC dysphagia management.Study Design: Retrospective review of all patients undergoing CARD following HNC treatment between May 2001 and September 2008.Methods: Forty‐five patients were identified for review. Parameters assessed included: ability to obtain intraoperative esophageal patency, complications, number of dilations required, diet, and gastric tube (GT) status. Factors associated with dilation failure were analyzed.Results: Intraoperative esophageal patency was obtained in 91% of patients. Median number of all dilations per patient was three. Median number of CARDs per patient was one. Resumption of oral intake occurred in 36/45 (80%). Diet results included: regular or soft diet 32/45 (71%), GT removal 27/45 (60%), and GT dependence with nothing by mouth 9/45 (20%). Laryngeal and pharyngeal stenosis, radionecrosis, tracheotomy dependence, and elongated stenosis were associated with dilation failure. Complications occurred in 18/63 (29%) CARD procedures: eight pneumomediastinum, seven GT site problems, two esophageal perforations, and one pharyngeal infection. All complications resolved spontaneously or with minimal interventions.Conclusions: CARD was safe and effective. Intraoperative patency was achieved in 91% of patients. Eighty percent resumed oral intake. The majority of patients had their GTs removed and resumed a soft or regular diet. Dilation failure was associated with laryngeal, pharyngeal, and excessively long esophageal stenosis, often resulting from radionecrosis. Complications were minor. CARD should be considered before relegating patients with complete esophageal stenosis to chronic GT dependence or subjecting them to laryngopharyngo esophagectomy. Laryngoscope, 2010Keywords
This publication has 42 references indexed in Scilit:
- Long-Term Outcomes and Toxicity of Concurrent Paclitaxel and Radiotherapy for Locally Advanced Head-and-Neck CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck CancerNew England Journal of Medicine, 2007
- Increasing Toxicity in Nonoperative Head and Neck Cancer Treatment: Investigations and InterventionsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Impact of dysphagia on quality of life after treatment of head-and-neck cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual dataThe Lancet, 2000
- Dilation of Esophageal Strictures: Comparative Morbidity of Antegrade and Retrograde MethodsAnnals of Otology, Rhinology & Laryngology, 1988